Cleared Traditional

IMRX SYSTEM V1 AND IMRISNV/IMRISCARDIO (K101813) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K101813 · Imris, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2010
Decision
98d
Days
Class 2
Risk

K101813 is an FDA 510(k) clearance for the IMRX SYSTEM V1 AND IMRISNV/IMRISCARDIO. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Imris, Inc. (Rockville, US). The FDA issued a Cleared decision on October 5, 2010 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Imris, Inc. devices

Submission Details

510(k) Number K101813 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2010
Decision Date October 05, 2010
Days to Decision 98 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 107d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 431
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K101813.
SYNGO MR B19 FOR MAGNETOM AVANTO, SYNGO MR B19 FOR MAGNETOM ESPREE, SYNGO MR B19 FOR MAGNETOM SYMPHONY A TIM SYSTEM, SYN
K123938 · Siemens Medical Solutions USA, Inc. · Feb 2013
MAGNETOM SPECTRA
K121160 · Siemens Medical Solutions USA, Inc. · Jul 2012
MAGNETOM AERA AND MAGNETOM SKYRA
K111242 · Siemens Medical Solutions USA, Inc. · Nov 2011
MAGNETOM AERA
K101347 · Siemens Medical Solutions USA, Inc. · Oct 2010
SYNGO BREVIS
K090038 · Siemens Medical Solutions USA, Inc. · Apr 2009
SYNGO MR B17
K082427 · Siemens Medical Solutions USA, Inc. · Nov 2008